New study: a weight-loss drug eased sleep apnea
StrongTwo phase 3 trials in the New England Journal of Medicine found tirzepatide reduced breathing interruptions by roughly 20 to 25 more events an hour than placebo over a year, in adults who had moderate to severe obstructive sleep apnea alongside obesity. This is a prescription-only medicine and this card is education, not a suggestion to seek it out: whether it fits you is a conversation with your doctor, and it was studied alongside, not instead of, standard apnea care.